Capricor Therapeutics Inc (CAPR) returns
Capricor Therapeutics returns over 10 years
$1,000 invested in Capricor Therapeutics ten years ago was worth $196.31 at the close on October 30, 2026, with dividends reinvested: an average return of -15.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -32.6% | — | $673.71 | -0.9% |
| 3 months | +52.3% | — | $1,523 | +2.1% |
| Year to date | -77.9% | — | $221.07 | +11.7% |
| 1 year | +2.7% | — | $1,027 | +12.4% |
| 3 years | +130.3% | +32.1% | $2,303 | +88.5% |
| 5 years | +71.5% | +11.4% | $1,715 | +76.0% |
| 10 years | -80.4% | -15.0% | $196.31 | +316.6% |
Capricor Therapeutics return by calendar year
| Year | CAPR | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -77.9% | +11.7% | -89.6% |
| 2025 | +109.1% | +17.7% | +91.4% |
| 2024 | +182.2% | +24.9% | +157.3% |
| 2023 | +26.7% | +26.2% | +0.5% |
| 2022 | +31.7% | -18.2% | +49.9% |
| 2021 | -14.6% | +28.7% | -43.3% |
| 2020 | +168.0% | +18.4% | +149.6% |
| 2019 | -68.8% | +31.2% | -100.0% |
| 2018 | -74.1% | -4.6% | -69.5% |
| 2017 | -40.6% | +21.7% | -62.3% |
| 2016 | -13.5% | +12.0% | -25.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: CAPR financials
No forecast, no recommendation. This page describes Capricor Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.